Drug intelligence / Profile preview

Qidan Bimin Pill

Development stage: Unknown
Lead developer: Tiansheng Pharmaceutical Group
Modality: Small Molecules
Administration: Oral

Overview

Qidan Bimin Pill is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shanxi Yangwenshui Pharmaceutical Co., Ltd. for the treatment of seasonal allergic rhinitis. The drug is a Chinese patent medicine (Zhongchengyao) composed of several herbal ingredients, including Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), and Magnolia biondii (Xin Yi). Its therapeutic action is based on traditional principles of tonifying the lungs and spleen while clearing the nasal passages. Pharmacologically, it is thought to work by stabilizing mast cell membranes, inhibiting the release of inflammatory mediators such as histamine, and modulating the Th1/Th2 immune balance to reduce hypersensitivity in the nasal mucosa. It is administered orally in a pill format and is approved for marketing in China.

Brand names: Qidan Bimin Pill
Other names: Qidan Bimin Wan芪丹鼻敏丸

Targets

IL-4 (Interleukin 4)IL-5 (Interleukin 5)

Beyond the preview

Go deeper on Qidan Bimin Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qidan Bimin Pill.

Explore the full profile